Table 2.
Clinical characteristics and hospital course data for patients readmitted within 30 days and those not readmitted.
| Clinical Characteristic | Not Readmitted | Readmitted | P-value |
|---|---|---|---|
| Initial GCS, median [IQR] | 14 [10–15] | 14 [10–15] | 0.8 |
| Initial GCS≤8, N (%) | 32 (19%) | 4 (18%) | 1 |
| Admission NIHSS, median [IQR] |
7 [3–16] | 11 [3–19] | 0.4 |
| Initial ICH Score, median [IQR] |
1 [0–1] | 1 [0–1] | 1 |
| APACHE Acute Physiology Score* |
32 [20–45] | 30 [20–44] | 1 |
| APACHE IV Predicted ICU LOS (days)* |
4.7 [4.1–6.3] | 5.3 [4.7–5.7] | 0.1 |
| Initial ICH Volume (cm3), median [IQR] |
10 [4–20] | 8 [4–24] | 0.7 |
| ICH location, n(%) | |||
| Lobar | 62 (36%) | 6 (27%) | 0.4 |
| Non-Lobar | 110 (64%) | 16 (73%) | |
| Thalamus | 44 (26%) | 9 (41%) | |
| Cerebellar | 10 (6%) | 1 (4%) | |
| Lentiform Nucleus | 35 (20%) | 4 (18%) | |
| Caudate | 7 (4%) | 0 (0%) | |
| Brainstem | 6 (3%) | 1 (4%) | |
| Other | 8 (5%) | 1 (4%) | |
| Intraventricular Hemorrhage Present |
67 (39%) | 9 (41%) | 1 |
| Admission INR, median [IQR] |
1.1 [1–1.2] | 1 [1–1.1] | 0.8 |
| Ventilator Free Days in First 14 days of Initial Admission, median [IQR] |
14 [6–14] | 13 [6–14] | 0.7 |
| Days Febrile within 14 days of ICH onset, median [IQR] |
1 [0–4] | 3 [1–6] | 0.08 |
| Pneumonia During Initial Admission, n (%) |
19 (11%) | 5 (23%) | 0.1 |
| Craniotomy During Initial Admission, n (%) |
22 (13%) | 3 (14%) | 0.9 |
| Extraventricular Drain During Initial Admission, N (%) |
38 (22%) | 7 (32%) | 0.3 |
| Percutaneous Endoscopic Gastrostomy Tube During Initial Admission, n (%) |
43 (25%) | 7 (32%) | 0.5 |
| Tracheostomy During Initial Admission, n (%) |
36 (21%) | 6 (27%) | 0.5 |
GCS=Glasgow coma score, IQR=interquartile range, NIHSS=National Institute of Health Stroke Scale, ICH=Intracerebral Hemorrhage, APACHE= Acute Physiology Age Chronic Health Evaluation, LOS=Length of Stay
*
APACHE IV data was only available at our institution for patients admitted after January 1st 2010, which constitutes 10 readmitted and 59 not-readmitted patients in this cohort.